Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 8.24B | 7.79B | 7.95B | 8.07B | 8.15B | 6.28B |
Gross Profit | 982.00M | 1.16B | 360.00M | 1.45B | 1.47B | 988.00M |
EBITDA | -36.50M | 1.16B | -621.00M | 1.24B | 1.23B | 631.00M |
Net Income | -1.09B | 200.00M | -1.68B | 322.00M | 265.00M | -178.00M |
Balance Sheet | ||||||
Total Assets | 14.09B | 13.99B | 14.88B | 16.76B | 16.37B | 15.70B |
Cash, Cash Equivalents and Short-Term Investments | 950.00M | 825.00M | 785.00M | 402.00M | 561.00M | 586.00M |
Total Debt | 6.28B | 6.53B | 6.96B | 7.41B | 7.12B | 4.27B |
Total Liabilities | 8.55B | 8.34B | 9.39B | 9.66B | 9.64B | 9.26B |
Stockholders Equity | 5.01B | 5.11B | 4.99B | 6.68B | 6.33B | 6.06B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 632.00M | 622.00M | -389.00M | -2.77B | -880.00M |
Operating Cash Flow | 0.00 | 817.00M | 728.00M | -204.00M | 687.00M | -149.00M |
Investing Cash Flow | 0.00 | 132.00M | 187.00M | -180.00M | -3.45B | -770.00M |
Financing Cash Flow | 0.00 | -909.00M | -512.00M | 216.00M | 2.74B | 597.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥56.91B | 5.28 | 4.74% | 4.12% | 192.18% | ||
74 Outperform | ¥81.99B | 9.33 | 4.14% | 4.87% | 5.07% | ||
73 Outperform | ¥17.89B | 6.99 | 4.53% | 0.79% | 60.97% | ||
73 Outperform | ¥23.96B | 7.34 | 3.07% | 9.75% | 28.00% | ||
64 Neutral | ¥2.26B | 11.10 | 1.34% | -2.00% | ― | ||
58 Neutral | HK$17.12B | 4.56 | -6.43% | 5.15% | -3.18% | -62.89% | |
55 Neutral | ¥7.86B | ― | ― | 20.71% | 0.54% |